This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
gene expression | 265 |
cell lines | 257 |
present study | 228 |
cell line | 216 |
flow cytometry | 206 |
breast cancer | 205 |
risk factors | 202 |
immune response | 194 |
abstract background | 184 |
important role | 169 |
plasma membrane | 164 |
mg kg | 155 |
endothelial cells | 154 |
epithelial cells | 147 |
cell death | 146 |
results show | 145 |
results suggest | 145 |
dendritic cells | 142 |
control group | 136 |
public health | 135 |
amino acid | 132 |
immune responses | 132 |
wild type | 132 |
bone marrow | 130 |
significantly higher | 130 |
oxidative stress | 128 |
blood pressure | 127 |
ng ml | 127 |
amino acids | 123 |
image quality | 123 |
class i | 122 |
performed using | 122 |
molecular dynamics | 121 |
lymph nodes | 121 |
heart failure | 120 |
western blot | 118 |
deficient mice | 118 |
cell proliferation | 117 |
cell surface | 116 |
significant differences | 116 |
cell culture | 114 |
dna damage | 113 |
cd cd | 113 |
results indicate | 111 |
mean age | 111 |
protein expression | 110 |
two different | 110 |
living cells | 108 |
cell activation | 108 |
immune system | 106 |
peripheral blood | 105 |
transcription factor | 104 |
smooth muscle | 101 |
health care | 100 |
risk factor | 100 |
first time | 99 |
cell responses | 98 |
signal transduction | 98 |
logistic regression | 98 |
cell cycle | 97 |
data suggest | 96 |
mass spectrometry | 96 |
statistically significant | 95 |
mrna expression | 93 |
blood samples | 93 |
myocardial infarction | 91 |
cell types | 90 |
dependent manner | 90 |
molecular weight | 90 |
united states | 89 |
significantly reduced | 89 |
significant difference | 89 |
significantly increased | 89 |
mg ml | 88 |
body weight | 88 |
molecular mechanisms | 87 |
side effects | 85 |
taken together | 85 |
single molecule | 85 |
tumor cells | 84 |
increased risk | 82 |
nkt cells | 82 |
binding site | 82 |
stem cells | 81 |
mouse model | 81 |
membrane proteins | 81 |
previous studies | 81 |
social distancing | 79 |
significant increase | 78 |
copyright holder | 76 |
real time | 75 |
ex vivo | 75 |
european countries | 74 |
type i | 74 |
electron microscopy | 73 |
fluorescence microscopy | 73 |
mhc class | 73 |
granted medrxiv | 73 |
results obtained | 73 |
lipid membranes | 73 |
wide range | 72 |
author funder | 72 |
monoclonal antibodies | 71 |
hek cells | 71 |
made available | 71 |
cell membrane | 71 |
cancer risk | 71 |
dna methylation | 71 |
international license | 70 |
expression levels | 70 |
cancer cells | 70 |
signaling pathways | 69 |
conformational changes | 69 |
high resolution | 68 |
exome sequencing | 68 |
membrane potential | 67 |
data show | 67 |
reactive oxygen | 67 |
specific cd | 67 |
spiral ct | 66 |
growth rate | 65 |
doc id | 65 |
dynamics simulations | 65 |
high levels | 65 |
binding sites | 65 |
infected cells | 65 |
lung cancer | 65 |
cord uid | 65 |
mast cells | 64 |
infectious diseases | 64 |
oxygen species | 64 |
atomic force | 63 |
one patient | 63 |
three different | 62 |
ion channels | 62 |
blot analysis | 62 |
muscle cells | 62 |
whole blood | 62 |
light scattering | 62 |
fatty acids | 62 |
transgenic mice | 62 |
pg ml | 61 |
innate immune | 61 |
preliminary results | 61 |
general population | 61 |
lipid bilayer | 61 |
data indicate | 60 |
time points | 60 |
cohort study | 60 |
results demonstrate | 59 |
intensive care | 59 |
free energy | 59 |
confocal microscopy | 59 |
mr imaging | 59 |
signal intensity | 58 |
lipid bilayers | 58 |
force microscopy | 58 |
binding protein | 58 |
heart disease | 57 |
energy transfer | 57 |
may contribute | 57 |
least one | 56 |
inkt cells | 56 |
cytokine production | 56 |
recent years | 56 |
lymph node | 56 |
slice thickness | 56 |
model system | 56 |
cell viability | 56 |
stem cell | 55 |
growth factor | 55 |
membrane protein | 55 |
may also | 55 |
united kingdom | 55 |
culture medium | 55 |
analysis revealed | 55 |
patients underwent | 55 |
fluorescent protein | 54 |
nervous system | 54 |
protein kinase | 54 |
high affinity | 54 |
contrast agent | 54 |
family members | 54 |
clinical trials | 54 |
version posted | 53 |
coronary artery | 53 |
knockout mice | 53 |
escherichia coli | 53 |
findings suggest | 53 |
acute respiratory | 53 |
two groups | 53 |
significantly lower | 52 |
skeletal muscle | 52 |
widely used | 52 |
significantly different | 52 |
different types | 52 |
blood flow | 52 |
healthy controls | 52 |
transcription factors | 51 |
child health | 51 |
supply chain | 51 |
contrast enhancement | 51 |
better understanding | 51 |
metabolic syndrome | 50 |
time pcr | 50 |
extracellular matrix | 50 |
protein interactions | 50 |
vg vd | 50 |
large number | 50 |
platelet aggregation | 50 |
cd cells | 50 |
cells showed | 50 |
ligand binding | 50 |
magnetic resonance | 50 |
factor viii | 50 |
intellectual disability | 50 |
dna repair | 50 |
coupled receptors | 50 |
generation sequencing | 50 |
molecular biology | 49 |
cancer cell | 49 |
data sets | 49 |
commonly used | 49 |
adverse effects | 49 |
confidence interval | 49 |
consecutive patients | 49 |
lactic acid | 49 |
allowed us | 49 |
sovereign citizens | 49 |
present work | 49 |
type ii | 49 |
pharmakologie und | 49 |
multislice ct | 48 |
ms ms | 48 |
chemical engineering | 48 |
also observed | 48 |
using different | 48 |
pulmonary embolism | 48 |
wp use | 48 |
results showed | 48 |
experimental data | 48 |
age groups | 48 |
enzyme activity | 47 |
also found | 47 |
high risk | 47 |
regression analysis | 47 |
actin cytoskeleton | 47 |
one year | 47 |
crucial role | 47 |
recent studies | 47 |
inflammatory cytokines | 47 |
und toxikologie | 47 |
risk assessment | 47 |
strand breaks | 47 |
key role | 47 |
well known | 47 |
mortality rates | 47 |
cell type | 46 |
patients without | 46 |
mental health | 46 |
fluorescence spectroscopy | 46 |
negatively charged | 46 |
platelet activation | 46 |
fatty acid | 46 |
cells expressing | 46 |
carotid artery | 46 |
activated protein | 46 |
saccharomyces cerevisiae | 46 |
cellular processes | 45 |
venous thrombosis | 45 |
specific antibodies | 45 |
nitric oxide | 45 |
analysis showed | 45 |
high level | 45 |
inflammatory response | 45 |
cell receptor | 45 |
target genes | 45 |
last years | 45 |
apc resistance | 44 |
presenting cells | 44 |
western blotting | 44 |
age years | 44 |
cell response | 44 |
helical ct | 44 |
climate change | 44 |
kg bw | 44 |
colorectal cancer | 44 |
fluorescence intensity | 43 |
median age | 43 |
apoptotic cells | 43 |
showed significant | 43 |
cell growth | 43 |
respiratory syndrome | 43 |
immune cells | 43 |
animal models | 43 |
medrxiv preprint | 43 |
first step | 43 |
antigen presentation | 43 |
per day | 43 |
candidate genes | 43 |
per year | 43 |
monoclonal antibody | 42 |
type mice | 42 |
healthy volunteers | 42 |
single cell | 42 |
dengue fever | 42 |
allows us | 42 |
platelet count | 42 |
cell cultures | 42 |
drug delivery | 42 |
plasma levels | 42 |
even though | 42 |
circular dichroism | 42 |
data demonstrate | 42 |
coupled receptor | 42 |
correlation spectroscopy | 42 |
expression level | 42 |
significantly decreased | 41 |
linear regression | 41 |
respiratory tract | 41 |
predictive value | 41 |
fold higher | 41 |
i molecules | 41 |
endothelial cell | 41 |
cardiac hypertrophy | 41 |
human genetics | 41 |
year old | 41 |
highly conserved | 41 |
sovereign citizen | 41 |
clinical signs | 41 |
commercially available | 41 |
active cases | 41 |
data analysis | 41 |
molecular level | 41 |
ang ii | 41 |
genes involved | 40 |
lung tissue | 40 |
tumor cell | 40 |
spatial resolution | 40 |
patients showed | 40 |
cell membranes | 40 |
influenza virus | 40 |
next generation | 40 |
may provide | 40 |
i will | 40 |
primary human | 40 |
cell development | 40 |
may play | 40 |
long term | 40 |
data obtained | 40 |
significantly associated | 40 |
mononuclear cells | 40 |
patients treated | 39 |
one case | 39 |
reporter gene | 39 |
mammalian cells | 39 |
contrast medium | 39 |
previously described | 39 |
early stage | 39 |
cell migration | 39 |
cell adhesion | 39 |
cell differentiation | 39 |
family history | 39 |
age group | 39 |
left ventricular | 39 |
target cells | 39 |
mouse models | 38 |
years old | 38 |
measured using | 38 |
serum levels | 38 |
primary care | 38 |
binding proteins | 38 |
may lead | 38 |
developmental delay | 38 |
investigate whether | 38 |
time point | 38 |
healthy donors | 38 |
exponential growth | 38 |
plasma samples | 38 |
surface expression | 38 |
poorly understood | 38 |
severe acute | 38 |
central role | 37 |
drinking water | 37 |
induced apoptosis | 37 |
low molecular | 37 |
standard deviation | 37 |
inhibitory effect | 37 |
new cases | 37 |
antigen presenting | 37 |
resonance energy | 37 |
two patients | 37 |
studies showed | 37 |
mitochondrial membrane | 37 |
room temperature | 37 |
autoimmune diseases | 37 |
cardiovascular disease | 37 |
major role | 37 |
significant reduction | 37 |
cell populations | 37 |
different stages | 37 |
technical university | 36 |
novel coronavirus | 36 |
healthy subjects | 36 |
investigated using | 36 |
birth weight | 36 |
type diabetes | 36 |
adipose tissue | 36 |
amyloid fibrils | 36 |
different concentrations | 36 |
statistical analysis | 36 |
different time | 36 |
cytauxzoon sp | 36 |
cell biology | 36 |
determined using | 36 |
clinical data | 36 |
diagnostic accuracy | 36 |
colon cancer | 36 |
diabetes mellitus | 35 |
viral infection | 35 |
contrast enhanced | 35 |
will present | 35 |
migration background | 35 |
obtained using | 35 |
flow cytometric | 35 |
protein level | 35 |
protein complexes | 35 |
ko mice | 35 |
central nervous | 35 |
signaling pathway | 35 |
provide evidence | 35 |
may represent | 35 |
fold increase | 35 |
health status | 35 |
epidemiological studies | 35 |
similar results | 35 |
physiological conditions | 35 |
secondary structure | 35 |
nucleic acids | 35 |
angiotensin ii | 34 |
complex i | 34 |
th cells | 34 |
digital mammography | 34 |
determine whether | 34 |
recombinant proteins | 34 |
confidence intervals | 34 |
molecular mechanism | 34 |
infected individuals | 34 |
closely related | 34 |
resonance imaging | 34 |
also known | 34 |
total number | 34 |
cardiac function | 34 |
mast cell | 34 |
carbon source | 34 |
case numbers | 34 |
cancer patients | 34 |
change points | 34 |
low concentrations | 34 |
fluorescence correlation | 34 |
regression model | 34 |
calculated using | 34 |
class ii | 33 |
gel electrophoresis | 33 |
laser scanning | 33 |
mechanical properties | 33 |
clinical symptoms | 33 |
autosomal recessive | 33 |
receptor activation | 33 |
data set | 33 |
fluorescent proteins | 33 |
analysis using | 33 |
mechanisms underlying | 33 |
significant decrease | 33 |
soft tissue | 33 |
adaptive immune | 33 |
electron transfer | 33 |
prospective study | 33 |
proteins involved | 33 |
previously reported | 33 |
patients undergoing | 33 |
conformational change | 33 |
live cells | 33 |
mass index | 33 |
cardiovascular risk | 33 |
global child | 32 |
fusion protein | 32 |
model membranes | 32 |
vitro studies | 32 |
will provide | 32 |
university hospital | 32 |
bcg vaccination | 32 |
protein levels | 32 |
gene therapy | 32 |
metabolic engineering | 32 |
converting enzyme | 32 |
new therapeutic | 32 |
gold standard | 32 |
data collection | 32 |
differential diagnosis | 32 |
april th | 32 |
double strand | 32 |
different levels | 32 |
comet assay | 32 |
control study | 32 |
large scale | 32 |
endoplasmic reticulum | 32 |
tissue factor | 31 |
protein structure | 31 |
citric acid | 31 |
whole exome | 31 |
treated cells | 31 |
normal range | 31 |
avian influenza | 31 |
recombinant protein | 31 |
coronary heart | 31 |
vascular smooth | 31 |
animal model | 31 |
inhibitory effects | 31 |
mrna levels | 31 |
hla class | 31 |
plasma concentrations | 31 |
necrosis factor | 31 |
biological activity | 31 |
significant effect | 31 |
patients suffering | 31 |
acute myocardial | 31 |
cell population | 31 |
protective effect | 31 |
odds ratios | 31 |
physical activity | 31 |
two weeks | 31 |
coal phase | 31 |
natural killer | 31 |
positive control | 31 |
significant changes | 31 |
dynamic light | 31 |
weight loss | 31 |
structural changes | 31 |
disease progression | 30 |
vitro model | 30 |
health insurance | 30 |
human plasma | 30 |
five patients | 30 |
cardiovascular diseases | 30 |
may help | 30 |
increased expression | 30 |
mr images | 30 |
positive correlation | 30 |
world health | 30 |
critical role | 30 |
life sciences | 30 |
contrast media | 30 |
influenza vaccination | 30 |
clinical features | 30 |
coronavirus disease | 30 |
dna adducts | 30 |
high quality | 30 |
mice showed | 30 |
new insights | 30 |
times higher | 30 |
acid production | 30 |
information regarding | 30 |
ca i | 30 |
genetic variants | 30 |
analyzed using | 30 |
cell carcinoma | 30 |
ml min | 30 |
alcohol consumption | 29 |
point mutation | 29 |
terminal domain | 29 |
nkt cell | 29 |
assessed using | 29 |
channel activity | 29 |
unilamellar vesicles | 29 |
adhesion molecules | 29 |
biological systems | 29 |
temporal resolution | 29 |
adrenergic receptor | 29 |
blood cells | 29 |
robert koch | 29 |
healthy individuals | 29 |
infection rates | 29 |
regression models | 29 |
plasma cells | 29 |
dna double | 29 |
genomic dna | 29 |
fuel stations | 29 |
diffusion coefficient | 29 |
fermentation process | 29 |
artery disease | 29 |
epithelial cell | 29 |
retail margins | 29 |
high concentrations | 29 |
federal states | 29 |
prostate cancer | 29 |
preliminary data | 29 |
mhc i | 29 |
better understand | 29 |
well established | 28 |
three times | 28 |
phase transition | 28 |
relative risk | 28 |
emergency department | 28 |
mm slice | 28 |
target protein | 28 |
host cell | 28 |
cell subsets | 28 |
previously shown | 28 |
high throughput | 28 |
largely unknown | 28 |
health effects | 28 |
human health | 28 |
human lung | 28 |
evaluated using | 28 |
bl mice | 28 |
posted may | 28 |
differentially expressed | 28 |
studied using | 28 |
protein coupled | 28 |
replacement therapy | 28 |
innate immunity | 28 |
ion channel | 28 |
sectional study | 27 |
mm collimation | 27 |
ct scans | 27 |
sanger sequencing | 27 |
chain reaction | 27 |
powerful tool | 27 |
remains unclear | 27 |
control measures | 27 |
aged years | 27 |
clinical trial | 27 |
long time | 27 |
ankara university | 27 |
oxygen transfer | 27 |
autosomal dominant | 27 |
lipid rafts | 27 |
cardiac fibroblasts | 27 |
highly sensitive | 27 |
hela cells | 27 |
cells using | 27 |
reproduction number | 27 |
infected mice | 27 |
significant correlation | 27 |
pivotal role | 27 |
tg mice | 27 |
compound heterozygous | 27 |
german health | 27 |
inflammatory diseases | 27 |
body mass | 27 |
ischemic stroke | 27 |
blood donors | 27 |
human skin | 27 |
signalling pathways | 27 |
ovarian cancer | 27 |
inflammatory bowel | 27 |
seasonal influenza | 27 |
health organization | 27 |
bat species | 27 |
neurodegenerative diseases | 27 |
high dose | 27 |
polymerase chain | 27 |
generalized anxiety | 26 |
adverse events | 26 |
porcine epidemic | 26 |
wall thickening | 26 |
new infections | 26 |
small bowel | 26 |
spinal cord | 26 |
biological processes | 26 |
morphological changes | 26 |
artery stenosis | 26 |
health system | 26 |
one hand | 26 |
higher levels | 26 |
low levels | 26 |
among others | 26 |
vein thrombosis | 26 |
inflammatory responses | 26 |
specific differences | 26 |
two main | 26 |
us purpose | 26 |
four patients | 26 |
confocal laser | 26 |
may result | 26 |
global health | 26 |
systematic review | 26 |
arterial phase | 26 |
supplementary material | 26 |
virus replication | 26 |
investigated whether | 26 |
infectious disease | 26 |
tumor necrosis | 26 |
molecular basis | 26 |
serum albumin | 26 |
several studies | 26 |
case report | 26 |
perceived threat | 26 |
present results | 26 |
enzymatic activity | 26 |
fluorescence lifetime | 26 |
whole body | 26 |
different countries | 26 |
well characterized | 26 |
useful tool | 26 |
mice lacking | 26 |
receptor potential | 26 |
host cells | 25 |
affinity chromatography | 25 |
concentration range | 25 |
cell survival | 25 |
cell wall | 25 |
red blood | 25 |
corona crisis | 25 |
much higher | 25 |
first results | 25 |
particle size | 25 |
computed tomography | 25 |
elderly patients | 25 |
proinflammatory cytokines | 25 |
higher concentrations | 25 |
among patients | 25 |
time series | 25 |
federal ministry | 25 |
gene transcription | 25 |
antigen processing | 25 |
statistical significance | 25 |
experimental conditions | 25 |
confirmed cases | 25 |
fusion proteins | 25 |
radiation exposure | 25 |
human umbilical | 25 |
umbilical vein | 25 |
european union | 25 |
pancreatic cancer | 25 |
low dose | 25 |
ray scattering | 25 |
liver metastases | 25 |
multiple sclerosis | 25 |
wt mice | 25 |
virus infection | 25 |
like receptor | 25 |
stress response | 25 |
transient receptor | 25 |
immune cell | 25 |
nk cells | 25 |
takes place | 25 |
dendritic cell | 25 |
cardiac myocytes | 25 |
financial support | 24 |
metal ions | 24 |
recently developed | 24 |
experimental results | 24 |
iron oxide | 24 |
ros production | 24 |
clinical studies | 24 |
short stature | 24 |
bacillus subtilis | 24 |
fluorescence resonance | 24 |
slice ct | 24 |
good correlation | 24 |
may explain | 24 |
cells treated | 24 |
acid residues | 24 |
false positive | 24 |
trpc channels | 24 |
scanning microscopy | 24 |
previously published | 24 |
bank vole | 24 |
koch institute | 24 |
three patients | 24 |
renal failure | 24 |
molecule fluorescence | 24 |
membrane fusion | 24 |
tissue samples | 24 |
hepatocellular carcinoma | 24 |
bladder cancer | 24 |
target proteins | 24 |
experiments revealed | 24 |
vaccination coverage | 24 |
plasminogen activator | 24 |
source markets | 24 |
study population | 24 |
time course | 24 |
published data | 24 |
promoter activity | 24 |
clotting time | 24 |
expressing cells | 24 |
antimicrobial peptides | 24 |
health services | 24 |
mg dl | 24 |
highly expressed | 24 |
mice compared | 24 |
cell signaling | 24 |
middle east | 24 |
previous work | 24 |
differentially methylated | 24 |
two types | 24 |
tr te | 24 |
transgenic mouse | 23 |
may cause | 23 |
full length | 23 |
different cell | 23 |
relatively high | 23 |
may influence | 23 |
quantitative analysis | 23 |
quality control | 23 |
contrast agents | 23 |
kiggs wave | 23 |
creative commons | 23 |
tourism flows | 23 |
protein folding | 23 |
active site | 23 |
dose reduction | 23 |
acute phase | 23 |
vat rate | 23 |
high sensitivity | 23 |
phasianus colchicus | 23 |
white matter | 23 |
cell division | 23 |
will show | 23 |
urine samples | 23 |
reproduction numbers | 23 |
protein synthesis | 23 |
toxic effects | 23 |
septic shock | 23 |
vascular disease | 23 |
epidemic diarrhea | 23 |
producing cells | 23 |
human serum | 23 |
expression patterns | 23 |
elevated levels | 23 |
czech republic | 23 |
steady state | 23 |
cytotoxic effects | 23 |
four different | 23 |
using two | 23 |
functional analysis | 23 |
will also | 23 |
lipid membrane | 23 |
disease onset | 23 |
protein function | 23 |
infectious agents | 23 |
among women | 23 |
prospective cohort | 23 |
vat reduction | 23 |
model systems | 23 |
visual acuity | 23 |
green fluorescent | 23 |
ct colonography | 23 |
whole genome | 23 |
take place | 23 |
allow us | 23 |
chronic inflammatory | 23 |
dental services | 22 |
high prevalence | 22 |
law enforcement | 22 |
one week | 22 |
death rate | 22 |
hydrogen peroxide | 22 |
kinetic parameters | 22 |
prevalence rates | 22 |
college london | 22 |
bile duct | 22 |
relative risks | 22 |
animal testing | 22 |
nucleic acid | 22 |
surface area | 22 |
psychological distress | 22 |
second messenger | 22 |
control groups | 22 |
dependent protein | 22 |
genes encoding | 22 |
drug development | 22 |
titration calorimetry | 22 |
cervical cancer | 22 |
ionic strength | 22 |
vein endothelial | 22 |
neutron scattering | 22 |
also performed | 22 |
will help | 22 |
blood mononuclear | 22 |
functional role | 22 |
protein production | 22 |
much lower | 22 |
findings indicate | 22 |
claims data | 22 |
protein interaction | 22 |
national institute | 22 |
diagnostic tool | 22 |
present data | 22 |
viral infections | 22 |
power plants | 22 |
gene silencing | 22 |
renewable energy | 22 |
control cells | 22 |
showed high | 22 |
carotid arteries | 22 |
dna binding | 22 |
fully understood | 22 |
dna sequence | 22 |
volume zoom | 22 |
odds ratio | 22 |
ct findings | 22 |
pulmonary artery | 22 |
results will | 22 |
physiological functions | 22 |
german federal | 22 |
apoptotic cell | 22 |
increased levels | 22 |
aspergillus niger | 22 |
naturally occurring | 22 |
clinical practice | 22 |
surface plasmon | 22 |
high degree | 22 |
women aged | 22 |
like receptors | 22 |
hepg cells | 22 |
clinically relevant | 22 |
great britain | 22 |
chain length | 22 |
cell imaging | 22 |
gastrointestinal tract | 22 |
enhanced mri | 22 |
thrombin generation | 22 |
facs analysis | 22 |
also used | 22 |
mechanisms involved | 22 |
days post | 22 |
induced dna | 21 |
time period | 21 |
diagnostic value | 21 |
atherosclerotic lesions | 21 |
early stages | 21 |
raman spectroscopy | 21 |
willebrand factor | 21 |
deficient cells | 21 |
iu ml | 21 |
crispr cas | 21 |
bacterial infections | 21 |
contrast material | 21 |
analysed using | 21 |
also showed | 21 |
animal experiments | 21 |
results may | 21 |
tlr ligands | 21 |
new zealand | 21 |
biologically active | 21 |
viral load | 21 |
using flow | 21 |
mmol kg | 21 |
north rhine | 21 |
silver nanoparticles | 21 |
correlation coefficient | 21 |
viral rna | 21 |
fr purpose | 21 |
test system | 21 |
general health | 21 |
time consuming | 21 |
experiments showed | 21 |
control mice | 21 |
blood loss | 21 |
negative bacteria | 21 |
south korea | 21 |
proteolytic activity | 21 |
transduction pathways | 21 |
point scale | 21 |
tube current | 21 |
provide new | 21 |
spatial distribution | 21 |
induced activation | 21 |
patch clamp | 21 |
inflammatory processes | 21 |
future studies | 21 |
study provides | 21 |
tyrosine kinase | 21 |
biological membranes | 21 |
gene panel | 21 |
systemic lupus | 21 |
hydrophobic interaction | 21 |
gene encoding | 21 |
small intestine | 21 |
good agreement | 21 |
yeast extract | 21 |
physical properties | 21 |
human cells | 21 |
target gene | 21 |
dental caries | 21 |
soluble fibrin | 21 |
growth retardation | 21 |
cancer cases | 21 |
mr angiography | 21 |
inflammatory cytokine | 21 |
smoking status | 21 |
across countries | 21 |
age range | 21 |
point mutations | 21 |
isothermal titration | 21 |
bovine serum | 21 |
quantitative real | 21 |
results indicated | 21 |
vitro methods | 21 |
sequence variants | 21 |
splice site | 21 |
base pairs | 21 |
culture conditions | 21 |
wistar rats | 21 |
substrate specificity | 21 |
positive cells | 21 |
still unknown | 21 |
two cases | 21 |
evidence suggests | 20 |
three days | 20 |
fat diet | 20 |
breast milk | 20 |
incubation period | 20 |
outer membrane | 20 |
well suited | 20 |
located within | 20 |
cellular uptake | 20 |
cytometric analysis | 20 |
image analysis | 20 |
degradation products | 20 |
surgical treatment | 20 |
pcr analysis | 20 |
tumor tissue | 20 |
health problems | 20 |
tumor growth | 20 |
aminophosphonic acids | 20 |
transcriptional regulation | 20 |
cancer therapy | 20 |
bleeding complications | 20 |
transcript levels | 20 |
dorsal root | 20 |
infected livers | 20 |
insulin resistance | 20 |
affected individuals | 20 |
acute coronary | 20 |
reaction center | 20 |
using data | 20 |
patients presenting | 20 |
mrna level | 20 |
increased significantly | 20 |
action potential | 20 |
binding affinity | 20 |
less pronounced | 20 |
model based | 20 |
volume rendering | 20 |
panel detector | 20 |
cell transformation | 20 |
pharmaceutical interventions | 20 |
may affect | 20 |
incidence rates | 20 |
new method | 20 |
remained unchanged | 20 |
protein kinases | 20 |
might also | 20 |
cumulative number | 20 |
diabetic rats | 20 |
mutation carriers | 20 |
therapeutic strategies | 20 |
case fatality | 20 |
essential role | 20 |
protein complex | 20 |
high concentration | 20 |
wide variety | 20 |
insulin secretion | 20 |
human blood | 20 |
directed mutagenesis | 20 |
live cell | 20 |
three months | 20 |
renal masses | 20 |
two radiologists | 20 |
adaptive immunity | 20 |
lipid composition | 20 |
hair follicle | 20 |
blood glucose | 20 |
march th | 20 |
within hours | 20 |
human cd | 20 |
stably transfected | 20 |
regarding covid | 20 |
disease spread | 20 |
probably due | 20 |
induced cell | 20 |
heart rate | 20 |
small number | 20 |
force spectroscopy | 20 |
factors associated | 19 |
clinical examination | 19 |
situ hybridization | 19 |
imaging techniques | 19 |
prothrombin time | 19 |
ray crystallography | 19 |
cell function | 19 |
syndrome coronavirus | 19 |
cellular functions | 19 |
human heart | 19 |
whole cell | 19 |
recent data | 19 |
receptor binding | 19 |
lower saxony | 19 |
normal human | 19 |
wound healing | 19 |
water molecules | 19 |
concentration dependent | 19 |
plasmon resonance | 19 |
may serve | 19 |
enhanced mr | 19 |
cross sectional | 19 |
psychological burden | 19 |
cells derived | 19 |
missense mutation | 19 |
transfected hek | 19 |
membrane interaction | 19 |
medium composition | 19 |
showed significantly | 19 |
coronary arteries | 19 |
negative predictive | 19 |
dipartimento di | 19 |
blood coagulation | 19 |
germany background | 19 |
one month | 19 |
mainly due | 19 |
increasing evidence | 19 |
small molecule | 19 |
movement disorder | 19 |
aortic wall | 19 |
md simulations | 19 |
tumor development | 19 |
blood vessels | 19 |
vivo studies | 19 |
informed consent | 19 |
research center | 19 |
lung injury | 19 |
rural areas | 19 |
color doppler | 19 |
six months | 19 |
studies show | 19 |
higher risk | 19 |
well tolerated | 19 |
culture model | 19 |
estrogen receptor | 19 |
crystal structure | 19 |
treated mice | 19 |
pilot study | 19 |
distancing measures | 19 |
mg i | 19 |
also investigated | 19 |
peer review | 19 |
particular interest | 19 |
effector cells | 19 |
optical tweezers | 19 |
new approach | 19 |
platelet function | 19 |
cystic fibrosis | 19 |
gene regulation | 19 |
platelet counts | 19 |
cell lysates | 19 |
previous study | 19 |
single nucleotide | 19 |
current study | 19 |
per ml | 19 |
flat panel | 19 |
embryonic stem | 19 |
frequently used | 19 |
studies revealed | 19 |
two major | 19 |
expression pattern | 19 |
liquid chromatography | 19 |
bowel disease | 19 |
mri findings | 19 |
induced platelet | 19 |
colon carcinoma | 19 |
presentation will | 19 |
bowel wall | 18 |
patients admitted | 18 |
oral anticoagulation | 18 |
oxide nanoparticles | 18 |
action potentials | 18 |
lupus erythematosus | 18 |
fluorescently labeled | 18 |
receptor expression | 18 |
culture supernatants | 18 |
luciferase reporter | 18 |
coal mining | 18 |
within one | 18 |
two distinct | 18 |
thrombin inhibitor | 18 |
working group | 18 |
human peripheral | 18 |
tandem mass | 18 |
case study | 18 |
heat shock | 18 |
weighted images | 18 |
ionizing radiation | 18 |
blood volume | 18 |
randomly selected | 18 |
respiratory symptoms | 18 |
mathematical model | 18 |
catalytic activity | 18 |
liver injury | 18 |
valuable tool | 18 |
regulated genes | 18 |
early detection | 18 |
actin filaments | 18 |
differential expression | 18 |
socioeconomic status | 18 |
nadph oxidase | 18 |
cd expression | 18 |
humoral immune | 18 |
study group | 18 |
intracellular ca | 18 |
single cells | 18 |
gastric cancer | 18 |
enabled us | 18 |
cumulative cases | 18 |
possible role | 18 |
deep vein | 18 |
ph values | 18 |
basal cells | 18 |
year period | 18 |
positively charged | 18 |
th cytokines | 18 |
multivariate analysis | 18 |
fluorescent probes | 18 |
rheumatoid arthritis | 18 |
bank voles | 18 |
iodinated contrast | 18 |
negative control | 18 |
cell functions | 18 |
coagulation factors | 18 |
th day | 18 |
thrombus formation | 18 |
control subjects | 18 |
phylogenetic analysis | 18 |
well understood | 18 |
ejection fraction | 18 |
human keratinocytes | 18 |
neutralizing antibodies | 18 |
coal regime | 18 |
pol ii | 18 |
antibody responses | 18 |
implant surgery | 18 |
using fluorescence | 18 |
ulcerative colitis | 18 |
expression profiles | 18 |
activation markers | 18 |
signalling pathway | 18 |
molecule level | 18 |
studies indicate | 18 |
gradient echo | 18 |
regulatory proteins | 18 |
retinal degeneration | 18 |
spin echo | 18 |
delivery system | 18 |
assay using | 18 |
second phase | 18 |
care system | 18 |
i antigen | 18 |
cancer registry | 18 |
upper airway | 18 |
using high | 18 |
heavy chain | 18 |
membrane surface | 18 |
study demonstrates | 18 |
detection rate | 18 |
may increase | 18 |
staphylococcus aureus | 18 |
patients aged | 18 |
flow rate | 18 |
ic values | 18 |
product formation | 18 |
two years | 18 |
diabetic patients | 18 |
veroe cells | 18 |
vitro assays | 18 |
binding domain | 18 |
various types | 18 |
clinical use | 18 |
renal function | 18 |
specific expression | 18 |
rna interference | 18 |
protein dynamics | 18 |
authors declare | 18 |
organic solvents | 18 |
ct angiography | 18 |
life cycle | 17 |
srw patients | 17 |
ca influx | 17 |
newly developed | 17 |
liver lesions | 17 |
regulatory role | 17 |
melanoma cells | 17 |
reverse transcription | 17 |
anaerobic conditions | 17 |
resolved fluorescence | 17 |
sample size | 17 |
cgmp signaling | 17 |
cells may | 17 |
optical properties | 17 |
nitrogen sources | 17 |
human macrophages | 17 |
using single | 17 |
crisis management | 17 |
dengue virus | 17 |
analyses revealed | 17 |
time scale | 17 |
fourier transform | 17 |
cord blood | 17 |
slice width | 17 |
und klinische | 17 |
time resolved | 17 |
results provide | 17 |
mass spectrometric | 17 |
clinical outcome | 17 |
molecular interactions | 17 |
van der | 17 |
gene delivery | 17 |
camp levels | 17 |
physical chemistry | 17 |
vivo experiments | 17 |
bacterial infection | 17 |
zeta potential | 17 |
cox proportional | 17 |
results reveal | 17 |
field digital | 17 |
ec ii | 17 |
high amounts | 17 |
two independent | 17 |
underlying mechanism | 17 |
metabolic pathways | 17 |
function mutations | 17 |
post infection | 17 |
domestic cats | 17 |
mammary gland | 17 |
dermal absorption | 17 |
cases data | 17 |
will allow | 17 |
bronchial epithelial | 17 |
cancer mortality | 17 |
vice versa | 17 |
positive predictive | 17 |
promoter region | 17 |
growth hormone | 17 |
cho cells | 17 |
hyaluronic acid | 17 |
selection bias | 17 |
three cases | 17 |
health microbiology | 17 |
cation channels | 17 |
phase i | 17 |
negative regulator | 17 |
amyloid aggregation | 17 |
total rna | 17 |
imaging findings | 17 |
scanning electron | 17 |
pregnant women | 17 |
pathological conditions | 17 |
therapeutic strategy | 17 |
monte carlo | 17 |
significant association | 17 |
may occur | 17 |
currently used | 17 |
clinical findings | 17 |
ct examinations | 17 |
significant change | 17 |
clinical diagnosis | 17 |
hacat cells | 17 |
tissue damage | 17 |
based approach | 17 |
showed increased | 17 |
differential scanning | 17 |
wildtype mice | 17 |
great interest | 17 |
lockdown measures | 17 |
patients referred | 17 |
carcinoma cells | 17 |
study shows | 17 |
growth rates | 17 |
damage response | 17 |
comparative analysis | 17 |
dominant negative | 17 |
respiratory disease | 17 |
immunological synapse | 17 |
term exposure | 17 |
outreach care | 17 |
carbon sources | 17 |
infrared spectroscopy | 17 |
mean follow | 17 |
correlated well | 17 |
bolus injection | 17 |
weight gain | 17 |
wp consumption | 17 |
causing mutations | 17 |
increasing number | 17 |
human monocytes | 17 |
method materials | 17 |
size distribution | 17 |
igg antibodies | 17 |
fatality rate | 17 |
less severe | 17 |
bile acid | 17 |
treated patients | 17 |
first case | 17 |
consumer products | 17 |
burkitt lymphoma | 17 |
excision repair | 17 |
genes associated | 17 |
well defined | 17 |
nuclear translocation | 17 |
glioma cells | 17 |
approach based | 17 |
high pressure | 17 |
like cells | 16 |
natural products | 16 |
service utilization | 16 |
protective role | 16 |
estimated using | 16 |
strong evidence | 16 |
patients received | 16 |
supported lipid | 16 |
mitochondria isolated | 16 |
cells compared | 16 |
proton transfer | 16 |
phosphorylation sites | 16 |
additional information | 16 |
protein stability | 16 |
fluorescence anisotropy | 16 |
three groups | 16 |
mass transfer | 16 |
hospital stay | 16 |
cation channel | 16 |
blood lymphocytes | 16 |
highly specific | 16 |
medical treatment | 16 |
light chain | 16 |
mouse line | 16 |
great potential | 16 |
national health | 16 |
increased incidence | 16 |
serum samples | 16 |
ethanol production | 16 |
phosphate buffer | 16 |
inclusion criteria | 16 |
high doses | 16 |
enzyme production | 16 |
heterozygous variants | 16 |
transmission electron | 16 |
energy metabolism | 16 |
surgical intervention | 16 |
cell lymphoma | 16 |
first report | 16 |
least two | 16 |
overall survival | 16 |
squamous cell | 16 |
disease causing | 16 |
study period | 16 |
recently identified | 16 |
relatively low | 16 |
three weeks | 16 |
data provide | 16 |
neuropathic pain | 16 |
culture system | 16 |
specific antibody | 16 |
significant improvement | 16 |
remaining patients | 16 |
fatal outcome | 16 |
drug resistance | 16 |
native dutch | 16 |
diarrhea virus | 16 |
different regions | 16 |
several proteins | 16 |
using various | 16 |
hazard ratio | 16 |
response element | 16 |
surface markers | 16 |
platelet reactivity | 16 |
cervical spine | 16 |
specific pcr | 16 |
lumbar spine | 16 |
many cases | 16 |
physicochemical properties | 16 |
throughput screening | 16 |
underlying mechanisms | 16 |
pathological findings | 16 |
minimally invasive | 16 |
study aims | 16 |
cardiac remodeling | 16 |
mitral valve | 16 |
derived macrophages | 16 |
viral replication | 16 |
genetic analysis | 16 |
stranded dna | 16 |
studies using | 16 |
von willebrand | 16 |
calcium influx | 16 |
propidium iodide | 16 |
airway inflammation | 16 |
near future | 16 |
study included | 16 |
high incidence | 16 |
daily number | 16 |
scanning calorimetry | 16 |
high expression | 16 |
retrospective analysis | 16 |
organic cation | 16 |
human cell | 16 |
planck institute | 16 |
optical microscopy | 16 |
atherosclerotic plaques | 16 |
autoimmune disease | 16 |
vaccination policy | 16 |
marker genes | 16 |
pressure overload | 16 |
model parameters | 16 |
short axis | 16 |
care unit | 16 |
thromboplastin time | 16 |
new insight | 16 |
healthcare workers | 16 |
dissociation constant | 16 |
electricity generation | 16 |
human platelets | 16 |
medium containing | 16 |
using standard | 16 |
homologous recombination | 16 |
data revealed | 16 |
kg body | 16 |
first wave | 16 |
three major | 16 |
results support | 16 |
macrophage activation | 16 |
consultation motives | 16 |
environmental factors | 16 |
data showed | 16 |
atrial fibrillation | 16 |
airway epithelium | 16 |
contracting dengue | 16 |
radiation dose | 16 |
cytokine release | 16 |
different tissues | 16 |
small molecules | 16 |
might contribute | 16 |
risk groups | 16 |
cardiovascular events | 16 |
transform infrared | 16 |
hard coal | 16 |
lipid vesicles | 16 |
allele frequency | 16 |
istituto di | 16 |
second step | 16 |
temperature range | 16 |
growth factors | 16 |
give rise | 16 |
posted june | 16 |
klinische pharmakologie | 16 |
epidemiological research | 16 |
drug targets | 16 |
patients compared | 16 |
receptor antagonist | 16 |
studies suggest | 16 |
healthy control | 16 |
also studied | 16 |
vgamma vdelta | 16 |
contact restrictions | 16 |
first weeks | 16 |
copy number | 16 |
bacterial growth | 16 |
side chain | 16 |
missense mutations | 16 |
mental retardation | 16 |
flow rates | 16 |
nursing staff | 16 |
digital subtraction | 16 |
human liver | 16 |
neuronal cells | 16 |
venous thromboembolism | 16 |
sle patients | 16 |
respiratory chain | 16 |
severe cases | 16 |
correlation coefficients | 16 |
subtraction angiography | 16 |
adrenergic stimulation | 15 |
environmental conditions | 15 |
organic acids | 15 |
cancer screening | 15 |
optical coherence | 15 |
higher sensitivity | 15 |
rate factors | 15 |
also detected | 15 |
expression vector | 15 |
randomized controlled | 15 |
retrospective study | 15 |
liver transplantation | 15 |
reported cases | 15 |
i ml | 15 |
clinical course | 15 |
different molecular | 15 |
solid phase | 15 |
opioid receptor | 15 |
gene cluster | 15 |
terminal region | 15 |
human exposure | 15 |
prolonged weaning | 15 |
dna vaccine | 15 |
factor vii | 15 |
small amounts | 15 |
calcium channels | 15 |
data acquisition | 15 |
anticholinergic drugs | 15 |
back pain | 15 |
public opinion | 15 |
also suggest | 15 |
target cell | 15 |
test results | 15 |
portal venous | 15 |
strongly suggest | 15 |
might play | 15 |
will discuss | 15 |
open access | 15 |
pandemic influenza | 15 |
inflammatory mediators | 15 |
beneficial effects | 15 |
tumor suppressor | 15 |
protein binding | 15 |
chronic inflammation | 15 |
ascorbic acid | 15 |
within days | 15 |
structural properties | 15 |
aortic arch | 15 |
di fisica | 15 |
hydration water | 15 |
low level | 15 |
complex formation | 15 |
showed similar | 15 |
radiation therapy | 15 |
giant unilamellar | 15 |
complete genome | 15 |
interaction chromatography | 15 |
cytokine expression | 15 |
health systems | 15 |
therapeutic approaches | 15 |
candidate gene | 15 |
mesenchymal stem | 15 |
wp tobacco | 15 |
children aged | 15 |
alternative oxidase | 15 |
anticoagulant therapy | 15 |
expression system | 15 |
research centre | 15 |
brain tissue | 15 |
mitochondrial dysfunction | 15 |
different mechanisms | 15 |
human genome | 15 |
cells also | 15 |
human body | 15 |
blood cell | 15 |
vessel wall | 15 |
old male | 15 |
soluble protein | 15 |
aqueous solutions | 15 |
recently shown | 15 |
cell level | 15 |
system using | 15 |
metabolic flux | 15 |
missing data | 15 |
muscular hypotonia | 15 |
identify novel | 15 |
storage phosphor | 15 |
female mice | 15 |
platelet surface | 15 |
examined using | 15 |
antibody response | 15 |
obtained results | 15 |
general practice | 15 |
time interval | 15 |
axial images | 15 |
kidney disease | 15 |
imaging modality | 15 |
freshly isolated | 15 |
great importance | 15 |
te ms | 15 |
thrombin inhibitors | 15 |
plasmid dna | 15 |
expression profiling | 15 |
bleeding time | 15 |
protective immunity | 15 |
step towards | 15 |
showed higher | 15 |
biophysical properties | 15 |
novel approach | 15 |
biological samples | 15 |
examine whether | 15 |
study aimed | 15 |
clavulanic acid | 15 |
mycobacterium tuberculosis | 15 |
heavy metals | 15 |
body temperature | 15 |
retention time | 15 |
data will | 15 |
high number | 15 |
chemical synthesis | 15 |
adv infection | 15 |
delivery systems | 15 |
mice treated | 15 |
barrier function | 15 |
second generation | 15 |
next step | 15 |
myocardial perfusion | 15 |
experiments show | 15 |
cell patch | 15 |
diffusion equation | 15 |
skin models | 15 |
vaccination rates | 15 |
power doppler | 15 |
sensory neurons | 15 |
strongly increased | 15 |
sir model | 15 |
physiological processes | 15 |
cells play | 15 |
protein aggregates | 15 |
cells stably | 15 |
four weeks | 15 |
ca release | 15 |
membrane lipids | 15 |
evaluate whether | 15 |
fundamental role | 15 |
time evolution | 15 |
dilution rate | 15 |
specific activity | 15 |
stably expressing | 15 |
structural information | 15 |
genome sequencing | 15 |
vitro experiments | 15 |
experimental studies | 15 |
influenza viruses | 15 |
food industry | 15 |
infected patients | 15 |
early onset | 15 |
influenza vaccine | 15 |
cytokine secretion | 15 |
gated ion | 15 |
water interface | 15 |
secondary metabolites | 15 |
dependent increase | 15 |
cases per | 15 |
induced phosphorylation | 15 |
acid bacteria | 15 |
demographic characteristics | 15 |
studies will | 15 |
tumor size | 15 |
data collected | 15 |
recently described | 15 |
federal state | 15 |
raw material | 14 |
three years | 14 |
tyrosine phosphorylation | 14 |
group showed | 14 |
platelet adhesion | 14 |
patients developed | 14 |
tumour cell | 14 |
small angle | 14 |
fibril formation | 14 |
first phase | 14 |
experimental animals | 14 |
patient groups | 14 |
therapeutic intervention | 14 |
salt concentration | 14 |
vitro study | 14 |
international supply | 14 |
beneficial effect | 14 |
potential role | 14 |
time resolution | 14 |
ubiquitously expressed | 14 |
active substances | 14 |
provide information | 14 |
magnetic field | 14 |
significantly enhanced | 14 |
german government | 14 |
protein content | 14 |
oral health | 14 |
phase ii | 14 |
develop new | 14 |
medical applications | 14 |
cirrhotic patients | 14 |
investigated pheasants | 14 |
intravenous injection | 14 |
educational level | 14 |
limited number | 14 |
coronary calcification | 14 |
liver cirrhosis | 14 |
high purity | 14 |
weighted sequences | 14 |
done using | 14 |
recombinant human | 14 |
broad spectrum | 14 |
also identified | 14 |
potential therapeutic | 14 |
calcium channel | 14 |
dose dependent | 14 |
taking advantage | 14 |
important step | 14 |
also evaluated | 14 |
acid sequence | 14 |
eukaryotic cells | 14 |
state university | 14 |
cytokine profile | 14 |
last decades | 14 |
axial length | 14 |
extensively studied | 14 |
hearing loss | 14 |
mortality rate | 14 |
random effects | 14 |
pcr products | 14 |
quantitative pcr | 14 |
group i | 14 |
using whole | 14 |
phase separation | 14 |
intestinal inflammation | 14 |
already known | 14 |
using confocal | 14 |
detailed analysis | 14 |
tissue sections | 14 |
cellular level | 14 |
normal controls | 14 |
gb purpose | 14 |
disease activity | 14 |
peptide binding | 14 |
gene mutations | 14 |
cerebral ischemia | 14 |
research institute | 14 |
photosystem ii | 14 |
internal reflection | 14 |
inflammatory cells | 14 |
high performance | 14 |
test systems | 14 |
critical cases | 14 |
thickness mm | 14 |
developmental stages | 14 |
renal cell | 14 |
intact cells | 14 |
hematopoietic stem | 14 |
cancer treatment | 14 |
ct data | 14 |
fiscal policy | 14 |
association studies | 14 |
myeloid cells | 14 |
per million | 14 |
tumour size | 14 |
incidence rate | 14 |
study showed | 14 |
heterologous expression | 14 |
immunodeficiency virus | 14 |
wall motion | 14 |
cox regression | 14 |
chronic diseases | 14 |
total cholesterol | 14 |
old boy | 14 |
patients affected | 14 |
biophysical chemistry | 14 |
infectious bursal | 14 |
study design | 14 |
lesser extent | 14 |
zinc finger | 14 |
calcium entry | 14 |
cycle progression | 14 |
synthetic peptides | 14 |
changes induced | 14 |
protective effects | 14 |
strongly reduced | 14 |
cancer incidence | 14 |
antithrombin iii | 14 |
pasteurella multocida | 14 |
intravenous administration | 14 |
enzymatic hydrolysis | 14 |
highly pathogenic | 14 |
tlr expression | 14 |
enables us | 14 |
vast majority | 14 |
tissue engineering | 14 |
bursal disease | 14 |
imperial college | 14 |
thermal stability | 14 |
bacterial species | 14 |
admission rates | 14 |
cytokine response | 14 |
disease caused | 14 |
coagulation factor | 14 |
related genes | 14 |
financial crisis | 14 |
normal values | 14 |
functional assays | 14 |
thrombin time | 14 |
structural features | 14 |
high mortality | 14 |
endovascular treatment | 14 |
two observers | 14 |
product sector | 14 |
adoptive transfer | 14 |
lung function | 14 |
screening program | 14 |
still unclear | 14 |
promising candidate | 14 |
weaning beds | 14 |
cells transfected | 14 |
mouse brain | 14 |
economic costs | 14 |
rat model | 14 |
rnase iii | 14 |
brain barrier | 14 |
solid state | 14 |
care units | 14 |
functional properties | 14 |
italian institute | 14 |
collagen i | 14 |
thrombolytic therapy | 14 |
vascular endothelial | 14 |
guanine nucleotide | 14 |
general practitioner | 14 |
mean values | 14 |
index patient | 14 |
electric field | 14 |
prognostic factors | 14 |
rate reduction | 14 |
tobacco smoking | 14 |
progenitor cells | 14 |
ml kg | 14 |
postmenopausal women | 14 |
different conditions | 14 |
copies per | 14 |
muscle contraction | 14 |
results demonstrated | 14 |
endothelial dysfunction | 14 |
dry weight | 14 |
dna strand | 14 |
ray diffraction | 14 |
took place | 14 |
patient characteristics | 14 |
cell epitopes | 14 |
adverse effect | 14 |
ax foci | 14 |
molecular modeling | 14 |
listeria monocytogenes | 14 |
early childhood | 14 |
primary cells | 14 |
higher prevalence | 14 |
possible mechanism | 14 |
polyethylene glycol | 14 |
mri examination | 14 |
chemokine receptor | 14 |
genetic testing | 14 |
birth cohort | 14 |
microarray analysis | 14 |
na ions | 14 |
genetic risk | 14 |
max planck | 14 |
arterial disease | 14 |
past years | 14 |
cells express | 14 |
nod mice | 14 |
dental service | 14 |
constitutively expressed | 14 |
catalytic domain | 14 |
significant effects | 14 |
model membrane | 14 |
rich plasma | 14 |
allergic asthma | 14 |
receptor signaling | 14 |
mri examinations | 14 |
crystal structures | 14 |
tr ms | 13 |
tissue distribution | 13 |
synaptic transmission | 13 |
gene assays | 13 |
pulmonary arteries | 13 |
low density | 13 |
civil society | 13 |
somatom volume | 13 |
socially deprived | 13 |
generally accepted | 13 |
protein aggregation | 13 |
clinical follow | 13 |
less sensitive | 13 |
neonatal rat | 13 |
nan doi | 13 |
cell number | 13 |
starting point | 13 |
available data | 13 |
binding assays | 13 |
cell morphology | 13 |
low affinity | 13 |
postnatal growth | 13 |
internal standard | 13 |
physiologically relevant | 13 |
antibodies directed | 13 |
cell numbers | 13 |
associated genes | 13 |
identify potential | 13 |
beta i | 13 |
treatment strategies | 13 |
marker cd | 13 |
optic nerve | 13 |
data available | 13 |
cell contacts | 13 |
skin sensitization | 13 |
doubling times | 13 |
fluorescent molecules | 13 |
chronic pain | 13 |
stop codon | 13 |
tested compounds | 13 |
older age | 13 |
low temperature | 13 |
clamp technique | 13 |
inflammatory properties | 13 |
linear model | 13 |
lipid peroxidation | 13 |
intracellular calcium | 13 |
wide association | 13 |
higher plants | 13 |
trp channels | 13 |
biological effects | 13 |
acyl chain | 13 |
vivo situation | 13 |
neurite outgrowth | 13 |
oral administration | 13 |
results also | 13 |
nuclear factor | 13 |
effective dose | 13 |
population decline | 13 |
lung inflammation | 13 |
rf ablation | 13 |
response rate | 13 |
significantly better | 13 |
literature review | 13 |
acetic acid | 13 |
fluorescence emission | 13 |
cells revealed | 13 |
surface receptors | 13 |
single molecules | 13 |
antigen specific | 13 |
mediated activation | 13 |
tightly regulated | 13 |
cases curves | 13 |
increased mortality | 13 |
induce apoptosis | 13 |
pathogenic variants | 13 |
biological function | 13 |
later stages | 13 |
singlet oxygen | 13 |
local recurrence | 13 |
partition coefficients | 13 |
basic reproduction | 13 |
pandemic seasons | 13 |
underwent mri | 13 |
ii activity | 13 |
allergic diseases | 13 |
hydrogen bonds | 13 |
thymidine incorporation | 13 |
currently available | 13 |
identified using | 13 |
different aspects | 13 |
activity assay | 13 |
pathogenic mutations | 13 |
university medical | 13 |
higher values | 13 |
using elisa | 13 |
normal tissue | 13 |
coherence tomography | 13 |
chronic conditions | 13 |
high frequency | 13 |
intrinsically disordered | 13 |
vascular diseases | 13 |
final diagnosis | 13 |
disease severity | 13 |
patients diagnosed | 13 |
see table | 13 |
gr purpose | 13 |
multislice spiral | 13 |
deprived districts | 13 |
echo sequences | 13 |
colour doppler | 13 |
findings show | 13 |
transmembrane domain | 13 |
mr examination | 13 |
noise ratio | 13 |
genetically modified | 13 |
und die | 13 |
specific immune | 13 |
immunized mice | 13 |
risk management | 13 |
high molecular | 13 |
study using | 13 |
higher production | 13 |
new covid | 13 |
first three | 13 |
interaction partners | 13 |
significantly elevated | 13 |
clinical presentation | 13 |
expression analysis | 13 |
gel filtration | 13 |
diagnostic quality | 13 |
distancing policies | 13 |
biological activities | 13 |
respiratory distress | 13 |
specific protein | 13 |
novo mutations | 13 |
molecular mass | 13 |
diseases like | 13 |
healthcare professionals | 13 |
fluid phase | 13 |
therapeutic target | 13 |
cytotoxic activity | 13 |
dengue infection | 13 |
mitochondrial function | 13 |
studied whether | 13 |
large amounts | 13 |
experiments using | 13 |
pharmacological inhibition | 13 |
two isoforms | 13 |
guinea pig | 13 |
peptides derived | 13 |
atpase activity | 13 |
ttc approach | 13 |
observation period | 13 |
icu beds | 13 |
fibrinolytic system | 13 |
case reports | 13 |
first study | 13 |
affinity binding | 13 |
inflammatory changes | 13 |
receptor antagonists | 13 |
regression analyses | 13 |
two months | 13 |
markedly reduced | 13 |
ct guided | 13 |
transmission rate | 13 |
differential equations | 13 |
fluorescence quenching | 13 |
using pcr | 13 |
real data | 13 |
study suggests | 13 |
sided migration | 13 |
induced il | 13 |
tested using | 13 |
might explain | 13 |
patients receiving | 13 |
toxicity studies | 13 |
first line | 13 |
drug design | 13 |
tlr stimulation | 13 |
quantitative rt | 13 |
cancer research | 13 |
mesangial cells | 13 |
lupus anticoagulant | 13 |
low concentration | 13 |
slight increase | 13 |
human embryonic | 13 |
measures taken | 13 |
first days | 13 |
fibrin monomer | 13 |
effector functions | 13 |
dna replication | 13 |
final concentration | 13 |
commons licence | 13 |
herpes simplex | 13 |
controlled trial | 13 |
likely due | 13 |
differentially regulated | 13 |
rational design | 13 |
metabolic activity | 13 |
pa activity | 13 |
castor oil | 13 |
adaptor proteins | 13 |
alternative splicing | 13 |
measurements using | 13 |
years ago | 13 |
therapeutic targets | 13 |
infected hepatocytes | 13 |
metabolic activation | 13 |
unemployment rate | 13 |
may reflect | 13 |
cultured cells | 13 |
signaling cascade | 13 |
drug discovery | 13 |
polycyclic aromatic | 13 |
initial results | 13 |
fuel prices | 13 |
million people | 13 |
connective tissue | 13 |
like structures | 13 |
factor receptor | 13 |
specific effects | 13 |
infection rate | 13 |
culture media | 13 |
speech recognition | 13 |
host immune | 13 |
old female | 13 |
also play | 13 |
increasing interest | 13 |
pertussis toxin | 13 |
time rt | 13 |
regulatory functions | 13 |
health information | 13 |
different methods | 13 |
physiological role | 13 |
high spatial | 13 |
old patient | 13 |
oecd tg | 13 |
clinical relevance | 13 |
higher among | 13 |
expression data | 13 |
surface antigen | 13 |
bladder neck | 13 |
antioxidant activity | 13 |
study investigates | 13 |
identified two | 13 |
signaling molecules | 13 |
insect cell | 13 |
screening programme | 13 |
cellular immune | 13 |
relative survival | 13 |
fl fl | 13 |
caspase activity | 13 |
brain regions | 13 |
thermo fisher | 13 |
brain tumors | 13 |
expression profile | 13 |
medical records | 13 |
structurally related | 13 |
east respiratory | 13 |
lipid interactions | 12 |
tlr ligand | 12 |
based medicine | 12 |
inclusion bodies | 12 |
per patient | 12 |
germline mutations | 12 |
lower levels | 12 |
two cell | 12 |
interacting proteins | 12 |
pheasant population | 12 |
specific interaction | 12 |
corpus callosum | 12 |
novel therapeutic | 12 |
pathogenic mutation | 12 |
detailed knowledge | 12 |
urinary tract | 12 |
expected number | 12 |
among children | 12 |
chemical properties | 12 |
com scientificreports | 12 |
critically involved | 12 |
one day | 12 |
influenza cases | 12 |
ccdc protein | 12 |
anticancer agents | 12 |
therapeutic potential | 12 |
social support | 12 |
luciferase activity | 12 |
different species | 12 |
monitored using | 12 |
incubation time | 12 |
disease states | 12 |
dna molecules | 12 |
zeigte sich | 12 |
serine protease | 12 |
technical success | 12 |
steroid hormones | 12 |
intervention group | 12 |
daily new | 12 |
using rt | 12 |
adjusted odds | 12 |
depressive symptoms | 12 |
human immunodeficiency | 12 |
stent implantation | 12 |
deep venous | 12 |
ct images | 12 |
fisher scientific | 12 |
deeper understanding | 12 |
heparin therapy | 12 |
one third | 12 |
acinar cells | 12 |
dependent cell | 12 |
intracellular cytokine | 12 |
current wp | 12 |
see also | 12 |
success rate | 12 |
life span | 12 |
also reduced | 12 |
standard protocol | 12 |
chronic illness | 12 |
syrian hamsters | 12 |
positive results | 12 |
observational study | 12 |
physiological function | 12 |
passive smoking | 12 |
cytometry analysis | 12 |
chemie gmbh | 12 |
also tested | 12 |
recently reported | 12 |
ros formation | 12 |
traction bronchioloectasis | 12 |
fluorescence microscope | 12 |
female patients | 12 |
leukemia cells | 12 |
dna sequencing | 12 |
lamina propria | 12 |
cell debris | 12 |
two hours | 12 |
widely accepted | 12 |
partial agonist | 12 |
current situation | 12 |
genetic cause | 12 |
remains unknown | 12 |
based analysis | 12 |
results confirm | 12 |
lifestyle factors | 12 |
negative correlation | 12 |
alpha synuclein | 12 |
last decade | 12 |
included patients | 12 |
test substances | 12 |
crude oil | 12 |
remain unclear | 12 |
venous blood | 12 |
transverse aortic | 12 |
lower respiratory | 12 |
contact time | 12 |
cerebrovascular emergencies | 12 |
drug candidates | 12 |
plant species | 12 |
genetic counseling | 12 |
adduct formation | 12 |
mother cell | 12 |
inhibitory activity | 12 |
chemical compounds | 12 |
second one | 12 |
erk thr | 12 |
activator inhibitor | 12 |
data support | 12 |
using specific | 12 |
directly related | 12 |
lactate dehydrogenase | 12 |
cyclic nucleotide | 12 |
tf expression | 12 |
lockdown policies | 12 |
derived dendritic | 12 |
living organisms | 12 |
food intake | 12 |
coronary angiography | 12 |
new technique | 12 |
expressing cd | 12 |
different forms | 12 |
death receptor | 12 |
ace activity | 12 |
detection limit | 12 |
dependent signaling | 12 |
mtt assay | 12 |
dynamic mri | 12 |
descriptive statistics | 12 |
glycyrrhizin concentrations | 12 |
yeast cells | 12 |
induced aggregation | 12 |
early diagnosis | 12 |
samples obtained | 12 |
membrane structure | 12 |
increased compared | 12 |
late phase | 12 |
glucose levels | 12 |
following parameters | 12 |
metabolic fluxes | 12 |
important factor | 12 |
treatment options | 12 |
shed light | 12 |
treated animals | 12 |
diagnostic performance | 12 |
proposed model | 12 |
picu admissions | 12 |
mice displayed | 12 |
current smoking | 12 |
receptor protein | 12 |
kg ha | 12 |
poisson regression | 12 |
testing strategies | 12 |
significantly improved | 12 |
folate intake | 12 |
rna copies | 12 |
also demonstrated | 12 |
universal bcg | 12 |
immune complexes | 12 |
arachidonic acid | 12 |
german population | 12 |
energy transition | 12 |
cases without | 12 |
healthy blood | 12 |
second half | 12 |
biotechnology institute | 12 |
secondary school | 12 |
among different | 12 |
type cells | 12 |
marrow derived | 12 |
free radicals | 12 |
shift towards | 12 |
many aspects | 12 |
cardiac contractility | 12 |
virus type | 12 |
shock protein | 12 |
based assay | 12 |
germinal center | 12 |
intracellular protein | 12 |
binding capacity | 12 |
portal vein | 12 |
activation kinetics | 12 |
virus strains | 12 |
protein unfolding | 12 |
high school | 12 |
neuronal death | 12 |
occlusive disease | 12 |
th week | 12 |
also show | 12 |
multiple myeloma | 12 |
predominantly expressed | 12 |
least three | 12 |
antimicrobial activity | 12 |
control animals | 12 |
cognitive function | 12 |
severe disease | 12 |
membrane binding | 12 |
physiological ph | 12 |
genomic damage | 12 |
optical density | 12 |
cytokine il | 12 |
transformation assay | 12 |
fold increased | 12 |
first pass | 12 |
air pollution | 12 |
important roles | 12 |
fever infection | 12 |
palliative care | 12 |
binding studies | 12 |
three dimensional | 12 |
nf deletions | 12 |
vivo model | 12 |
body condition | 12 |
provide insights | 12 |
showed reduced | 12 |
may act | 12 |
antibody levels | 12 |
high temperature | 12 |
higher frequency | 12 |
significant role | 12 |
nerve agents | 12 |
factor xii | 12 |
well plates | 12 |
different proteins | 12 |
fret experiments | 12 |
potassium channels | 12 |
member states | 12 |
negative controls | 12 |
antibody titers | 12 |
cyclic amp | 12 |
cell tolerance | 12 |
different kinds | 12 |
may indicate | 12 |
electron microscopic | 12 |
transcription units | 12 |
lifetime imaging | 12 |
carnitine supplementation | 12 |
tuberculosis infection | 12 |
clinical pharmacology | 12 |
bd patients | 12 |
induced cytokine | 12 |
group ii | 12 |
functional relevance | 12 |
bronchoalveolar lavage | 12 |
camp response | 12 |
samples collected | 12 |
newly identified | 12 |
animal studies | 12 |
systems biology | 12 |
cholesterol levels | 12 |
coronary syndromes | 12 |
controlled trials | 12 |
also able | 12 |
target sequence | 12 |
specific binding | 12 |
experimental study | 12 |
recent study | 12 |
months follow | 12 |
health interview | 12 |
aromatic hydrocarbons | 12 |
vitro models | 12 |
often used | 12 |
sars coronavirus | 12 |
caspase activation | 12 |
table shows | 12 |
many different | 12 |
comparative study | 12 |
infectious bronchitis | 12 |